Active Surveillance clinical trials
5 indexed studies · 3 currently recruiting
- Active not recruitingNA
Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment
This study compares current care for prostate cancer patients on active surveillance with a new approach. It aims to find the best time to start treatment to prevent cancer from getting worse, without giving unnecessary treatment or causing side effects.
For: Prostate CancerUnited Kingdom - Active not recruitingNA
SPCG17: Prostate Cancer Active Surveillance Trigger Trial
This study looks at how best to manage prostate cancer through 'active surveillance'. This means closely monitoring the cancer instead of immediate treatment. We want to find out if clear guidelines for monitoring can reduce unnecessary treatments while still keeping you safe.
For: Prostate CancerDenmark · Finland · Norway - Recruiting
The Active Surveillance Study
This study looks at men with prostate cancer on Active Surveillance to see how genetics and body markers might affect their cancer. It compares men with and without a higher genetic risk to understand how their cancer changes over time.
For: Prostate CancerUnited Kingdom - RecruitingNA
STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision
This study looks at treating early vulvar cancer. We want to see if checking for HPV and another marker (p53) can help doctors choose if surgery or just watching closely is best, potentially reducing treatment for some.
For: Vulvar Squamous Cell CarcinomaCanada · New Zealand - RecruitingNA
Steroid Sparing in Immune Related Hepatitis (irH)
This study looks at treating liver inflammation caused by cancer immunotherapy. It compares closely watching patients and only giving steroids if needed, versus giving steroids early. The aim is to find the best way to treat this condition with fewer side effects.
For: Hepatitis ImmuneCanada